TSC-101 is a T cell therapy made from genetically engineered donor T cells. This therapy is being studied for use in patients who have recently had a haploidentical stem cell transplant.
| SparkCures ID | 618 |
|---|---|
| Generic Name | TSC-101 |
| Treatment Classifications |
|
| Tags |
There are no resources, links or videos to display for this treatment.